Merck Chalks Up 2nd Fosamax Trial Win In NJ
By Juan-Carlos Rodriguez ( April 18, 2012, 5:02 PM EDT) -- Merck & Co. Inc. said Wednesday that a New Jersey state court jury found in its favor in a woman's suit claiming the company's osteoporosis drug Fosamax caused her jaw to deteriorate....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.